News
August 21 2020, SNN News
A new minimally invasive procedure at Sarasota Memorial Hospital helps to reduce the risk of Dialysis Treatment. Read Article. Watch Video.
June 2020, Endovascular Today
Roundtable Discussion: Percutaneous AV Fistulae: What to Expect in the Learning Curve
Perspectives on patient candidacy, technical challenges and follow-up protocols, considerations for cannulation, and steps for handling inadequate flow. Read Article.
April 22, 2020, Washington Examiner
WASHINGTON, DC – The world is facing an escalating pandemic unlike anything we’ve seen in our lifetimes. Read Article.
April 19, 2020, GoUpstate.com
SPARTANBURG, SOUTH CAROLINA – While much is still unknown about COVID-19, what is clear is that the virus is most deadly to people with underlying health issues. Read Article.
December 26, 2019, Richmond Times-Dispatch
Richmond doctor creates new, non-invasive procedure for dialysis patients
RICHMOND, VIRGINIA – Dr. Jeffrey Hull’s procedure reduces the time before a patient can start dialysis. Read Article.
December 11, 2019, Medscape Medical News
Percutaneous Device for Dialysis Access ‘a Significant Advance’
A new device for the percutaneous creation of an arteriovenous fistula (AVF) for hemodialysis access in patients with kidney disease has excellent cumulative patency rates out to 2 years and is associated with high levels of patient satisfaction, new research indicates. Read More.
October 4, 2019, Vascular News
“A yearly hub for innovation in vascular access”: i-VAS 2019 and beyond
PARIS, FRANCE – Following the 2019 International Vascular Access Symposium (i-VAS 2019; 13 September, Paris, France), current president Alexandros Mallios talks to Vascular News about his highlights of this year’s meeting, what we can look forward to next year, and what makes i-VAS stand out in the field of vascular access. Read Article.
September 30, 2019, Richmond Magazine
RICHMOND, VIRGINIA – A Richmond physician’s innovation may reduce risks for patients preparing for dialysis. Read Article.
September 3, 2019, Fresenius Medical Care North America
Vascular Access: Reducing Catheter Contact Time to Improve Clinical Outcomes and Reduce Cost of Care
Improving vascular access and reducing catheter contact time not only improve the health and lives of patients, but also can save the healthcare system millions of dollars each year. However, achieving this important goal requires significant coordination among all stakeholders, as well as a focus on best practices, data-driven metrics, and transformative technologies. Read More.
August 8, 2019, Med Tech Outlook Magazine
Ellipsys is a groundbreaking, minimally invasive and cost effective method to create a percutaneous arteriovenous fistula for hemodialysis access in patients with End-Stage Renal Disease. Read Article.
July 22, 2019, Los Angeles Business Journal
LOS ANGELES, CALIFORNIA – Last month at the Society for Vascular Surgery’s 2019 Vascular Annual Meeting, vascular surgeon Alexandros Mallios, M.D. of Institut Mutualiste Montsouris of Paris, France presented his two year experience performing non-surgical creation of AV fistulae utilizing the FDA cleared Ellipsys Vascular Access System from Southern California based Avenu Medical. Read More.
July 10, 2019, Department of Health and Human Services
Trump Signs Executive Order for Kidney Care Reform
WASHINGTON, DC – President Trump announces groundbreaking action to bring new hope to millions of Americans suffering from Kidney disease. Watch Video.
June 20, 2019, OR Today
Vascular Surgeon Presents Data on 216 Ellipsys EndoAVF System Procedures
PRINCE GEORGES, MARYLAND – At the Society for Vascular Surgery’s 2019 Vascular Annual Meeting in Maryland, vascular surgeon Alexandros Mallios, M.D., of Institut Mutualiste Montsouris of Paris, France presented on his two-year experience performing non-surgical creation of AV fistulae utilizing the FDA cleared Ellipsys Vascular Access System from Avenu Medical Inc. Read More.
March 26, 2019, The Journal of Vascular and Interventional Radiology (JVIR)
JVIR, SIR Foundation Spotlight Treatments for End-Stage Renal Disease and Diabetes
AUSTIN, TEXAS – Awards to study investigators given during Society of Interventional Radiology’s Annual Scientific Meeting in Austin, Texas. Read Article.
February 14, 2019, L’Echo Republican
CHARTRES, FRANCE – Chartres is the second hospital center in France to create arteriovenous fistulas percutaneously. This technique, used in outpatient surgery by vascular surgeon Dr. Alexandros Mallios, improves care for patients with kidney disease who are receiving dialysis. Read More.
February 6, 2019, U.S. Dept. of Veterans Affairs,
MUSKOGEE, OKLAHOMA – Last month, the Jack C. Montgomery VA Medical Center became the first VA facility to perform a new revolutionary vascular procedure for patients requiring hemodialysis, a treatment for kidney failure. Read More.
October 4, 2018, Business Wire
Richmond Vascular Center/Jeffrey Hull, M.D. First in Nation to Utilize FDA-approved Ellipsys System
RICHMOND, VIRGINIA – Richmond Vascular Center, Central Virginia’s state-of-the-art treatment center for Radiology Associates of Richmond and Surgical Associates of Richmond, is the first US site to offer the Ellipsys® Vascular Access System, a game-changing innovation for patients with End-Stage Renal Disease (ESRD). Read More.
September, 2018, Nephrology News & Issues
Fifteen years ago, CMS launched the Fistula First Breakthrough Initiative to encourage greater use of the arteriovenous fistula among patients with end-stage renal disease. Read More.
September 27, 2017, Paris Channel 5 TV
New endoAVF® technology in Europe
Dr. Mallios demonstrates new endoAVF® technology in Europe with the Ellipsys System. Watch Video.